Hypereosinophilia and Seroconversion of Rheumatoid Arthritis

被引:10
作者
Rosenstein, Rachel K. [1 ]
Panush, Richard S. [2 ]
Kramer, Neil [3 ]
Rosenstein, Elliot D. [3 ]
机构
[1] NYU, Dept Dermatol, Langone Sch Med, New York, NY 10016 USA
[2] Univ So Calif, Keck Sch Med, Div Rheumatol, Dept Med, Los Angeles, CA 90033 USA
[3] Overlook Med Ctr, Inst Rheumat & Autoimmune Dis, Summit, NJ 07902 USA
关键词
Cytokines; Eosinophilia; Rheumatoid arthritis; Rheumatoid factor; Tyrosine kinase; IMATINIB MESYLATE; BIOLOGICAL-PROPERTIES; EOSINOPHILIA; DISEASE; ETANERCEPT; DISORDERS; INNATE; HEALTH;
D O I
10.1007/s10067-014-2566-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
At the intersection of atopy and autoimmunity, we present a patient with seronegative rheumatoid arthritis (RA) who developed hypereosinophilia, without evidence of other etiologies, as she became rheumatoid factor (RF) positive. Although the magnitude of eosinophilia in patients with RA has been thought to reflect the severity or activity of the RA, in our patient, eosinophilia developed at a time when the patient's synovitis was well controlled. Although eosinophilia may reflect associated drug hypersensitivity, discontinuation of the medications utilized to control our patient's disease, adalimumab and methotrexate, did not promote clinical improvement. Probably the most curious aspect of our patient was the concomitant development of rheumatoid factor seropositivity in the setting of previously seronegative RA. The temporal relationship between the development of peripheral eosinophilia and seroconversion suggests a possible connection between these events. We speculate that the T cell cytokine production that can induce eosinophilia may simultaneously activate RF production.
引用
收藏
页码:1685 / 1688
页数:4
相关论文
共 27 条
[1]   Response to imatinib mesylate in patients with hypereosinophilic syndrome [J].
Arefi, Maryam ;
Garcia, Juan L. ;
Montserrat Briz, M. ;
de Arriba, Felipe ;
Rodriguez, Juan N. ;
Martin-Nunez, Guillermo ;
Martinez, Joaquin ;
Lopez, Javier ;
Suarez, Julio G. ;
Jose Moreno, M. ;
Angeles Merino, M. ;
Gutierrez, Norma C. ;
Maria Hernandez-Rivas, Jesus .
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2012, 96 (03) :320-326
[2]   Immune-mediated adverse effects of biologicals used in the treatment of rheumatic diseases [J].
Borchers, Andrea T. ;
Leibushor, Naama ;
Cheema, Gurtej S. ;
Naguwa, Stanley M. ;
Gershwin, M. Eric .
JOURNAL OF AUTOIMMUNITY, 2011, 37 (04) :273-288
[3]   Eosinophilic cellulitis (Wells' syndrome) as a cutaneous reaction to the administration of adalimumab [J].
Boura, P. ;
Sarantopoulos, A. ;
Lefaki, I. ;
Skendros, P. ;
Papadopoulos, P. .
ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 (06) :839-840
[4]   RESPONSE TO CORTICOSTEROIDS IN HYPEREOSINOPHILIC SYNDROME - ASSOCIATION WITH INCREASED SERUM IGE LEVELS [J].
BUSH, RK ;
GELLER, M ;
BUSSE, WW ;
FLAHERTY, DK ;
DICKIE, HA .
ARCHIVES OF INTERNAL MEDICINE, 1978, 138 (08) :1244-1246
[5]  
Cancelliere N, 2011, J INVEST ALLERG CLIN, V21, P248
[6]   HUMAN-LYMPHOCYTES MAKING RHEUMATOID-FACTOR AND ANTIBODY TO SSDNA BELONG TO LEU-1+ B-CELL SUBSET [J].
CASALI, P ;
BURASTERO, SE ;
NAKAMURA, M ;
INGHIRAMI, G ;
NOTKINS, AL .
SCIENCE, 1987, 236 (4797) :77-81
[7]   HYPEREOSINOPHILIC SYNDROME - ANALYSIS OF 14 CASES WITH REVIEW OF LITERATURE [J].
CHUSID, MJ ;
DALE, DC ;
WEST, BC ;
WOLFF, SM .
MEDICINE, 1975, 54 (01) :1-27
[8]   Treatment of rheumatoid arthritis with imatinib mesylate: clinical improvement in three refractory cases [J].
Eklund, KK ;
Joensuu, H .
ANNALS OF MEDICINE, 2003, 35 (05) :362-367
[9]   Tyrosine Kinase Inhibitors - A Review on Pharmacology, Metabolism and Side Effects [J].
Hartmann, Joerg Thomas ;
Haap, Michael ;
Kopp, Hans-Georg ;
Lipp, Hans-Peter .
CURRENT DRUG METABOLISM, 2009, 10 (05) :470-481
[10]  
HILLERDAL G, 1979, ACTA MED SCAND, V206, P429